Cable Hill Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-30
| Closed | -$2K | – | 446 |
|
2019
Q1 | $2K | Hold |
30
| – | – | ﹤0.01% | 756 |
|
2018
Q4 | $3K | Hold |
30
| – | – | ﹤0.01% | 663 |
|
2018
Q3 | $5K | Sell |
30
-5
| -14% | -$833 | ﹤0.01% | 568 |
|
2018
Q2 | $5K | Hold |
35
| – | – | ﹤0.01% | 662 |
|
2018
Q1 | $3K | Sell |
35
-60
| -63% | -$5.14K | ﹤0.01% | 772 |
|
2017
Q4 | $8K | Hold |
95
| – | – | ﹤0.01% | 621 |
|
2017
Q3 | $8K | Sell |
95
-3
| -3% | -$253 | ﹤0.01% | 643 |
|
2017
Q2 | $7K | Hold |
98
| – | – | ﹤0.01% | 481 |
|
2017
Q1 | $6K | Sell |
98
-1
| -1% | -$61 | ﹤0.01% | 505 |
|
2016
Q4 | $6K | Buy |
+99
| New | +$6K | ﹤0.01% | 517 |
|